Mary S Stack

Title: Mary S Stack: Innovator in Angiogenesis Research

Introduction

Mary S Stack is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of angiogenesis research. With a total of 3 patents, her work focuses on the development of compounds and methods that can either promote or inhibit angiogenesis, which is crucial for various medical applications.

Latest Patents

Her latest patents include innovative compositions and methods for promoting or inhibiting angiogenesis. These patents disclose compounds that bind to F1 ATP synthase, particularly to the alpha and/or beta subunits. When these compounds bind to the subunits, they can act as angiostatin agonists, antagonists, partial agonists, inverse agonists, or allosteric modulators. The compounds can mimic or enhance the activity of angiostatin, leading to the inhibition of angiogenesis. Conversely, if they inhibit the ability of angiostatin to bind F1 ATP synthase, they may promote angiogenesis. The compounds can take various forms, including antibodies, antibody fragments, enzymes, peptides, nucleic acids, or small molecules. These innovations have potential applications in treating disorders mediated by angiogenesis, such as tumors and autoimmune disorders.

Career Highlights

Mary has worked with prestigious institutions, including Northwestern University and Duke University. Her research has significantly advanced the understanding of angiogenesis and its implications in medical science.

Collaborations

Some of her notable coworkers include Salvatore Pizzo and Tammy L Moser, who have contributed to her research endeavors.

Conclusion

Mary S Stack's innovative work in angiogenesis research has led to valuable patents that hold promise for medical advancements. Her contributions continue to impact the field significantly.